Wave Life Sciences details Q3 2026 progress on WVE-006, WVE-007, WVE-008 pipelineOct 28Quarterly updateBristol Myers SquibbEli LillyUpdated
Aardvark Therapeutics adds biostatistics veteran David Zhang to boardOct 8PeopleAardvark Therapeutics, Inc.
BMS registers Phase 1 CAR T cell trial in kidney cancer; adds mavacamten real-world studyOct 1Weekly roundup, 5 itemsBristol Myers SquibbgolcadomideUpdated
FDA approves Camzyos for children with obstructive hypertrophic cardiomyopathySep 30Regulatory decisionBristol Myers Squibbmavacamten
Bristol Myers Squibb raises 2026 guidance, cites pipeline progress across four programsJul 30Quarterly updateBristol Myers Squibbluspatercept